Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Nobuhiko Hata
Brigham and Women's Hospital, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Mebio, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
See attached document for additional information
Enabling Technologies for MRI-Guided Prostate Interventions
Prostate care for prostate cancer, the most common cancer in men, is lacking given that TRUS, the most common diagnostic method for prostate cancer, misses cancer a significant percentage of the time. This R01 fills in a wide gap in public health by creating an image-guided system capable of focal image-defined targeted biopsy sampling and radiation therapy that will move to FDA device application and approval during this grant cycle. Such a system provides more targeted sampling for better understanding of prostate cancer and targeting and planning of therapy including radiation dosing during brachytherapy and, further, in the new cycle, TRUS can be optimized with MR parameters that are achievable at 3 Tesla that can provide information about focal cancers, and how to best treat them with minimal side-effects.
Filed on June 09, 2015.
Tell us what you know about Nobuhiko Hata's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Nobuhiko Hata”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Nobuhiko Hata | Brigham and Women's Hospital | Conflict of Interest | Mebio, Inc. | Value cannot be readily determined |
| Nobuhiko Hata | Brigham and Women's Hospital | Conflict of Interest | Harmonus | Value cannot be readily determined |
| Nobuhiko Hata | Brigham and Women's Hospital | Conflict of Interest | Harmonus | $60,000 - $79,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.